Evidence infrastructure
Reproducible source harvesting, provenance, deterministic validation, quality gating, source-monitoring and auditable public publication.
Business / due diligence
An inspectable research asset, not a sales claim.
SCC Vaping offers a transparent demonstration of evidence-infrastructure capability. Commercial collaboration must preserve research independence, data rights and publication controls.
Disclosure: This is a publication-safe project and submission-preparation page. It is not a peer-reviewed scientific finding, clinical advice, journal acceptance, investment offer or endorsement.
Potential collaboration
What can be examined
Scientific review operations
Governed study triage and human-review workbenches. These are capabilities under development, not a licensed diagnostic or validated clinical product.
Public transparency
Release manifests, safe aggregated statistics, research-integrity disclosure and traceable limitations designed for challenge and independent inspection.
Partnership governance
Prospective partnerships require declared conflicts, scientific independence, lawful reuse permissions, written scope and human approval.
Commercial readiness
Due-diligence checklist
| Review domain | Position | Required before contractual reliance |
|---|---|---|
| Technical demonstrator | Operational public release | Contract-specific availability and security verification |
| Academic claims | Not independently certified | Evidence review, frozen release and appropriate scholarly scrutiny |
| Clinical or regulatory claims | Not offered | Separate regulatory and clinical assessment where applicable |
| Data licences and IP | Rights must be checked | Record permissions by dataset, software component and proposed use |
| Revenue, TAM or valuation | Not asserted | Verified forecasts, unit economics and qualified financial review |
| Personal and restricted data | Excluded from public release | Data protection assessment and controlled access agreement |
This is a disclosure and enquiry pathway, not a prospectus, funding offer or business valuation.
Engage transparently
Request a scoped discussion
Potential collaborators can review the public methodology and read the disclosure boundary before requesting a restricted, role-specific due-diligence pack.
Independence: no commercial supporter, sponsor or third party is represented here as endorsing SCC Vaping. Any future financial relationship must be separately declared.